This Annual Report contains forward-looking statements. Forward-looking statements are not based on historical facts but rather on management’s expectations regarding future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Statements by Nobel Biocare about its future plans and intentions, results, levels of activity, performance, goals or achievements or other future events constitute forward-looking statements. Wherever possible, words such as “anticipate”, “believe”, “expect”, “may”, “could”, “will”, “potential”, “intend”, “estimate”, “should”, “plan”, “predict” or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. Such forward-looking statements reflect Nobel Biocare management’s current beliefs and assumptions and are based on information currently available to them. Forward-looking statements involve significant known and unknown risks, uncertainties and assumptions and other factors that may cause Nobel Biocare actual results, levels of activity, performance or achievements to differ materially from those implied by forward-looking statements. These factors should be considered carefully and undue reliance should not be placed on the forward-looking statements. Although the forward-looking statements are based upon what Nobel Biocare’s management believes to be reasonable assumptions, Nobel Biocare cannot assure investors that actual results will be consistent with these forward-looking statements. Nobel Biocare undertakes no obligation to update forward-looking statements to reflect events or circumstances that occur after the date the statements were made.
Nobel Biocare Holding AGP.O. Box, 8058 Zürich-Flughafen, Switzerland
Phone +41 43 211 42 00
The binding version of the Nobel Biocare Annual Report 2011 is in English. A condensed version is available in German.
Concept and design: New Identity Ltd., Basel, Switzerland
Editorial: Nobel Biocare Corporate Communications
Photographer: Stephan Knecht, Zurich, Switzerland
Prepress/Press: Linkgroup, Zurich, Switzerland
Printed in Switzerland.